Table 2.
Number of correct responses before and after the educational seminar
| Content | Correct response first time n (%) | Correct response second time n (%) | |
|---|---|---|---|
| 1. Organs involved | 48 (82.8) | 55 (94.8) | |
| 2. CNS composition | 25 (43.1) | 44 (75.9) | |
| 3. Prevalence | 18 (31) | 46 (79.3) | |
| 4. Lifespan | 32 (55.2) | 55 (94.8) | |
| 5. Immune disease | 39 (67.2) | 55 (94.8) | |
| 6. Contagiousness | 55 (94.8) | 57 (98.3) | |
| 7. Etiology | 12 (20.7) | 55 (94.8) | |
| 8. Genetics 1 | 31 (53.4) | 44 (75.9) | |
| 9. Genetics 2 | 14 (24.1) | 39 (67.2) | |
| 10. Myelin/axon* | 33 (56.9) | 27 (46.6) | |
| 11. Onset age | 36 (62.1) | 53 (91.4) | |
| 12. Gender | 37 (63.8) | 52 (89.7) | |
| 13. Myelin | 38 (65.5) | 49 (84.5) | |
| 14. Diagnosis 1 | 23 (39.7) | 40 (69.0) | |
| 15. MRI 1 | 48 (82.8) | 55 (94.8) | |
| 16. MRI 2* | 22 (37.9) | 21 (36.2) | |
| 17. MRI 3 | 45 (77.6) | 56 (96.6) | |
| 18. CSF 1 | 26 (44.8) | 46 (79.3) | |
| 19. CSF 2 | 13 (22.4) | 36 (62.1) | |
| 20. Diagnosis 2 | 32 (55.2) | 44 (75.9) | |
| 21. Course 1 | 18 (31.0) | 33 (56.9) | |
| 22. Benign MS | 16 (27.6) | 41 (70.7) | |
| 23. Pregnancy | 23 (39.7) | 50 (86.2) | |
| 24. Therapy 1 | 44 (75.9) | 52 (89.7) | |
| 25. Therapy 2 | 12 (20.7) | 30 (51.7) | |
| First round | Second round | p | |
| Number of correct answers, mean (SD)a | 12.8 (5.2) | 18.7 (3.2) | <0.01 |
a
Wilcoxon signed ranks test; CNS, Central nervous system; CSF, cerebrospinal fluid; MRI, magnetic resonance imaging; MS, multiple sclerosis; SD, standard deviation.